|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|
| Royalty revenue (Note 15) | |||
| Sales (Note 15) | |||
| Total revenue | |||
| Cost of sales, excluding depletion | |||
| Depletion (Note 5) | |||
| Total cost of sales | |||
| Gross profit | |||
| Administration expenses (Note 10) | |||
| Share-based compensation expense | |||
| Project evaluation expenses (Note 10) | |||
| Royalty interest impairment (Note 5b) | |||
| Adjustments for gains (losses) on change in fair value of prepaid gold interests | |||
| Income from operations | |||
| Other income and expenses | |||
| Gain on amendment of royalty interest (Note 4a) | |||
| Gain on royalty transactions (Note 4) | |||
| Gain on conversion of debenture (Note 4) | |||
| Foreign exchange (loss) gain | |||
| Other (expense) income | |||
| Finance expense | |||
| Income before income taxes | |||
| Income tax expense (Note 14) | |||
| Net income | |||
| Foreign currency translation | |||
| Item that will not be subsequently re-classified to net income: | |||
| Changes in fair value of investments, net of tax (Note 7) | |||
| Income tax expense on investments (Note 13) | |||
| Comprehensive income | |||
| Earnings per share (Note 11) | |||
| Basic earnings per share | |||
| Diluted earnings per share | |||
| Weighted average number of common shares outstanding: | |||
| Basic | |||
| Diluted |
Loading...
